Skip to main content
CLDX logo
CLDX
(NASDAQ)
Celldex Therapeutics, Inc.
$29.96-- (--)
Loading... - Market loading

Celldex Therapeutics (CLDX) Stock Price & Financial Analysis

Celldex Therapeutics Stock Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Day's Range$29.33 - $30.21
52-Week High$35.79
52-Week Low$19.52
Open$29.41
Volume949.46K
Average Volume (3M)735.37K
Market Cap1.95B
Shares Outstanding66.50M
Price to Sales (P/S)1301.18
Price to Book (P/B)3.70
EV/EBITDA-6.92
Revenue (TTM)1.50M
Net Income (TTM)-258.80M
Free Cash Flow (TTM)-213.37M
EPS (TTM)$-3.90
Profit Margin-17253.33%
Operating Margin-19160.00%
Return on Equity (ROE)-49.09%
Debt to Equity0.00
50-Day MA$31.95
200-Day MA$27.75
52-Week Change46.72%
Annual Dividend$0.00
Dividend Yield0.00%

Frequently Asked Questions About Celldex Therapeutics

What is the current stock price for CLDX?

As of the latest trading session, CLDX stock trades at $29.96. The 52-week range is $19.52–$35.79, with a day range of $29.33–$30.21.

What is the P/E ratio for CLDX?

The P/E ratio (Price-to-Earnings) for CLDX is shown in the Key Statistics section. This valuation metric helps compare Celldex Therapeutics, Inc. to industry peers.

Does CLDX pay dividends?

Celldex Therapeutics does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.

What do analysts recommend for CLDX?

Based on 1 analyst, the consensus for CLDX is Buy. The average 12-month price target is $NaN, representing a NaN% downside from the current price.

What is the market cap of CLDX?

Celldex Therapeutics's market capitalization is $1.99B, classifying it as a small-cap company. Celldex Therapeutics operates in the Healthcare sector within the Biotechnology industry.